🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ICYMI: What's the relationship b/t economic hardship & symptom distress for breast cancer patients prior to initiation of treatment? Read Margaret Rosenzweig's recent study on economic hardship in breast cancer patients, in print Clinical Breast Cancer: #hapc #pallcareresearch #nursetwitter

Dry Heat Treatment (Fluidotherapy) added to complete decongestive therapy lead to reduced pain and edema severity in patients with breast cancer related lymphedema. Read more about study 👇 #bcsm #CBCjournal pubmed.ncbi.nlm.nih.gov/38565462/

The Importance of Naming Structural Racism as a Root Cause of Racial Inequities in Breast Cancer Outcomes👇 #bcsm #RacialDisparities #CBCjournal Sydney Habert, MD clinical-breast-cancer.com/article/S1526-…

Study 🚨highlighting an opportunity to identify candidates for axillary de-escalation, potentially reducing morbidity and tailoring treatment more closely to individual patient needs. Read 👇 #bcsm #CBCjournal Boston Breast Surgeon Samir Mitri, MD clinical-breast-cancer.com/article/S1526-…

A phase I study of alpelisib + capecitabine in pts with MBC showed that combination is safe and well-tolerated oral regimen. Treatment responses were observed regardless of HR and PIK3CA status. Read more👇 #bcsm Yara Abdou, MD, MSCR Carey Anders Lisa Carey, MD, ScM, FASCO sciencedirect.com/science/articl…

Axillary involvement is linked to increased risk of distant metastasis, read more about metastatic mechanisms sciencedirect.com/science/articl… Figure👇 illustrates the intricate mechanisms of programming the SLN microenvironment to become a metastatic niche. Professor Kefah Mokbel The Princess Grace Hospital #bcsm

Check out on Clinical Breast Cancer our review of comparative evidence from clinical studies with metronomic versus standard-dose regimens. Dario Trapani Elena Battaiotto clinical-breast-cancer.com/article/S1526-…

A new study in Clinical Breast Cancer shows mobile #mammography helps increase breast cancer screening in underserved areas, especially among Indigenous, rural, & low-income women. It complements facility-based screenings and improves early detection. #HealthEquity bit.ly/HPI_MobileMammo

A Clinical Review of Subcutaneous (SC) Trastuzumab and Pertuzumab in treating early-stage and metastatic HER2+ BC, highlighting benefits of SC vs IV formulations. Check out more 👇 Antoinette Tan, MD, MHSc, FACP, FASCO @levinecancer Atrium Health #bcsm #CBCjournal pubmed.ncbi.nlm.nih.gov/39567339/

Effect of BC Receptor Subtypes and CSF Cytology Status on Survival of BC Patients w/ Leptomeningeal Disease. #bcsm Clinical Breast Cancer ajay dhakal Carey Anders Ruth O'Regan Wilmot Cancer Institute Duke Cancer pubmed.ncbi.nlm.nih.gov/39521703/

NH Black women have ⬆️ risk of TNBC yet, they are less likely to undergo genetic counseling / testing and less likely to receive guideline-directed screening and risk-reduction compared to NH White women. #bcsm #disparities Demetria Smith-Graziani, MD, MPH Winship Cancer Institute of Emory University pubmed.ncbi.nlm.nih.gov/39477723/

A Clinical Review of the Role of Immunotherapy in TNBC, with an Overview of Data from Seminal Trials for both Early and Advanced TNBC. #bcsm Rita Nanda UChicago Medicine pubmed.ncbi.nlm.nih.gov/38582617/

Just published in the February 2025 issue of Clinical Breast Cancer Clinical Breast Cancer Congratulations to Professor Yihong Wang and colleagues The Warren Alpert Medical School Legorreta Cancer Center at Brown University Brown Pathology and Laboratory Medicine     In our study of 224 node-positive breast cancer patients treated with neoadjuvant

A Clinical Review on Antibody-Drug Conjugates in TNBC, summarizing Current Data and Future Developments. Merve KESKINKILIC Winship Cancer Institute of Emory University pubmed.ncbi.nlm.nih.gov/38341370/

🔔Hot off the press! Optimizing Postneoadjuvant Treatment of Residual #BreastCancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy 🔓Free access until 03/21: sciencedirect.com/science/articl… ✍️Clinical Breast Cancer Dario Trapani Qingchun Jin Hope Rugo Yara Abdou, MD, MSCR

A study evaluating forequarter amputation (FA) in BC (locally advanced/recurrent tumor, Stewart & Treves syndrome, radiation-induced sarcoma) showed that FA has few complications & attenuates symptoms in pts tx with both curative & palliative intent. sciencedirect.com/science/articl…

Radiation omission in pts w/ early BC is a dynamically changing paradigm. Individualizing treatment is paramount and understanding an individual pt's goals of treatments and values is key. Read more 👇 #bcsm Roswell Park Simon Fung-Kee-Fung MD Mark Farrugia Chirag Shah clinical-breast-cancer.com/article/S1526-…

PreciseDx Breast is a digital risk assessment test that predicts early BC recurrence within 6-years of diagnosis. Read more👇 #bcsm Icahn School of Medicine at Mount Sinai clinical-breast-cancer.com/article/S1526-…